Published in J Clin Oncol on June 15, 2001
European Low and Intermediate Risk Neuroblastoma Protocol | NCT01728155
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification. Br J Cancer (2007) 1.39
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project. Br J Cancer (2012) 1.09
Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth. Cancer Biol Ther (2014) 0.93
High level amplification of N-MYC is not associated with adverse histology or outcome in primary retinoblastoma tumours. Br J Cancer (2002) 0.86
Morus alba Accumulates Reactive Oxygen Species to Initiate Apoptosis via FOXO-Caspase 3-Dependent Pathway in Neuroblastoma Cells. Mol Cells (2015) 0.86
PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer. Nat Med (2016) 0.85
Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma. Virchows Arch (2008) 0.83
Leucine to proline substitution by SNP at position 197 in Caspase-9 gene expression leads to neuroblastoma: a bioinformatics analysis. 3 Biotech (2012) 0.78
Neuroblastoma cell death is induced by inorganic arsenic trioxide (As(2)O(3)) and inhibited by a normal human bone marrow cell-derived factor. Cancer Microenviron (2008) 0.77
Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science (1990) 8.91
A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell (2000) 6.14
Y-chromosomal diversity in Europe is clinal and influenced primarily by geography, rather than by language. Am J Hum Genet (2000) 4.72
AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa. N Engl J Med (1986) 4.68
Effects of P element insertions on quantitative traits in Drosophila melanogaster. Genetics (1992) 4.65
Water-borne outbreak of campylobacter gastroenteritis. Lancet (1983) 3.97
Investigation of a Campylobacter jejuni outbreak by serotyping and chromosomal restriction endonuclease analysis. J Clin Microbiol (1984) 3.54
Polyacrylamide gel electrophoresis of spiral bacteria from the gastric antrum. Lancet (1984) 3.52
Variations in behavior and condition of a Southern Ocean top predator in relation to in situ oceanographic conditions. Proc Natl Acad Sci U S A (2007) 3.04
Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med (1999) 3.03
KP elements repress P-induced hybrid dysgenesis in Drosophila melanogaster. EMBO J (1987) 2.98
Antigenic analysis of Campylobacter flagellar protein and other proteins. J Clin Microbiol (1985) 2.92
Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development (2000) 2.82
Guidance for contained field trials of vector mosquitoes engineered to contain a gene drive system: recommendations of a scientific working group. Vector Borne Zoonotic Dis (2008) 2.49
The identification of outer membrane proteins and flagella of Campylobacter jejuni. J Gen Microbiol (1984) 2.42
Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endoscopy. J Clin Pathol (1986) 2.38
Intestinal permeability in children with Crohn's disease and coeliac disease. Br Med J (Clin Res Ed) (1982) 2.36
In vivo nuclear transport kinetics in Saccharomyces cerevisiae: a role for heat shock protein 70 during targeting and translocation. J Cell Biol (1996) 2.33
Estimating Scandinavian and Gaelic ancestry in the male settlers of Iceland. Am J Hum Genet (2000) 2.22
Elevated serum concentrations of beta-tryptase, but not alpha-tryptase, in Sudden Infant Death Syndrome (SIDS). An investigation of anaphylactic mechanisms. Clin Exp Allergy (2001) 2.15
Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients. Cell Death Differ (2002) 2.14
Variants of hepatic arterial supply in a Caribbean population: a computed tomography based study. Clin Radiol (2013) 2.13
Environmental isolation of heat-tolerant Campylobacter in the Southampton area. Lancet (1978) 2.12
Clinico-pathological findings in non-immune hydrops fetalis. Ir Med J (1991) 2.05
Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases. J Clin Pathol (1984) 1.98
Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group. J Clin Oncol (1993) 1.93
Quality assessment of genetic markers used for therapy stratification. J Clin Oncol (2003) 1.92
Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res (1997) 1.91
Ototoxicity of cisplatinum in children and adolescents. Br J Cancer (1990) 1.88
European Y-chromosomal lineages in Polynesians: a contrast to the population structure revealed by mtDNA. Am J Hum Genet (1998) 1.87
Nucleus-vacuole junctions in Saccharomyces cerevisiae are formed through the direct interaction of Vac8p with Nvj1p. Mol Biol Cell (2000) 1.86
The virulence of clinical and environmental isolates of Campylobacter jejuni. J Hyg (Lond) (1985) 1.82
A critical evaluation of HIPE data. Ir Med J (2012) 1.77
Saccharomyces cerevisiae Nip7p is required for efficient 60S ribosome subunit biogenesis. Mol Cell Biol (1997) 1.76
Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma. Eur J Cancer (1992) 1.76
A very large PC LAN as the basis for a hospital information system. J Med Syst (1991) 1.76
Campylobacter-associated diarrhoea in Southampton. Br Med J (1977) 1.75
Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study. J Clin Oncol (1995) 1.74
Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy. Arch Surg (2000) 1.71
'Active learning in the UK undergraduate dental course'. Br Dent J (1994) 1.71
Almost two centuries with amalgam: where are we today? J Am Dent Assoc (1994) 1.68
Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study. J Clin Oncol (1998) 1.66
Strain variation in Campylobacter pylori detected by numerical analysis of one-dimensional electrophoretic protein patterns. Antonie Van Leeuwenhoek (1989) 1.64
Small cell tumours in childhood: a review. J Pathol (1985) 1.64
Pulmonary tuberculosis in Harare, Zimbabwe: analysis by spoligotyping. Thorax (1998) 1.64
Genetic evidence for a family-based Scandinavian settlement of Shetland and Orkney during the Viking periods. Heredity (Edinb) (2005) 1.59
Silver-stained structures (AgNORs), their dependence on tissue fixation and absence of prognostic relevance in rectal adenocarcinoma. J Pathol (1989) 1.57
Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br J Cancer (1984) 1.56
Risk factors for ifosfamide nephrotoxicity in children. Lancet (1996) 1.56
Delayed visual maturation: ophthalmic and neurodevelopmental aspects. Dev Med Child Neurol (1990) 1.55
Modulated high-energy gamma-ray emission from the microquasar Cygnus X-3. Science (2009) 1.55
Ifosfamide nephrotoxicity: limited influence of metabolism and mode of administration during repeated therapy in paediatrics. Eur J Cancer (1996) 1.54
The imprint of the extragalactic background light in the gamma-ray spectra of blazars. Science (2012) 1.53
Clinical effectiveness of transversus abdominis plane (TAP) block in abdominal surgery: a systematic review and meta-analysis. Colorectal Dis (2012) 1.53
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line. Cancer Res (2001) 1.52
Response to N7 induction chemotherapy in children more than one year of age diagnosed with metastatic neuroblastoma treated in UKCCSG centers. Pediatr Blood Cancer (2007) 1.49
Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr (2000) 1.48
Long-term fecal excretion and resistance induced in mice infected with Yersinia enterocolitica. Infect Immun (1978) 1.47
Is Mycoplasma hominis a vaginal pathogen? Sex Transm Infect (2001) 1.46
The need for endoscopic biopsy in the diagnosis of upper gastrointestinal graft-versus-host disease. J Pediatr Gastroenterol Nutr (1993) 1.44
Intestinal disease in cystic fibrosis. Arch Dis Child (1988) 1.43
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Genetic counselling for schizophrenia in the era of molecular genetics. Can J Psychiatry (2001) 1.41
Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax (1999) 1.41
Diagnosis of fetal submicroscopic chromosomal abnormalities in failed array CGH samples: copy number by sequencing as an alternative to microarrays for invasive fetal testing. Ultrasound Obstet Gynecol (2015) 1.41
Massive pulmonary emboli associated with olanzapine. Ir Med J (2008) 1.41
Nasogastric drug administration. Prof Nurse (1998) 1.40
Assessing the dietetic needs of different patient groups receiving enteral tube feeding in primary care. J Hum Nutr Diet (2002) 1.40
Intracranial calcification in survivors of childhood medulloblastoma. Arch Dis Child (1983) 1.39
Association between diaphragm use and urinary tract infection. JAMA (1985) 1.38
Decline in incidence of medulloblastoma in children. Cancer (1994) 1.38
Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors. Am J Pathol (2001) 1.38
Case of tularaemia in England. Br Med J (1972) 1.37
Single incision laparoscopic surgery in general surgery: a review. Ann R Coll Surg Engl (2011) 1.36
Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer (1992) 1.36
Defects of metabolism of fatty acids in the sudden infant death syndrome. Br Med J (Clin Res Ed) (1985) 1.34
Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. Climacteric (2005) 1.33
Primary endovascular repair of juxtarenal aneurysms with fenestrated endovascular grafting. Eur J Vasc Endovasc Surg (2004) 1.33
The extent of surface contamination of retailed chickens with Campylobacter jejuni serogroups. Epidemiol Infect (1988) 1.32
Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992. Eur J Cancer (2000) 1.32
Investigation of inborn errors of metabolism in unexpected infant deaths. Lancet (1988) 1.31
Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology (2002) 1.31
An evaluation of accelerated Portland cement as a restorative material. Biomaterials (2002) 1.31
Acquired isodisomy for chromosome 13 is common in AML, and associated with FLT3-itd mutations. Leukemia (2005) 1.31
Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem (1990) 1.28
Cheese-borne listeria meningitis in immunocompetent patient. Lancet (1989) 1.28
Effect of Pseudomonas aeruginosa rhamnolipids on mucociliary transport and ciliary beating. J Appl Physiol (1985) (1992) 1.27
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br J Cancer (2002) 1.26
Increase in severity of graft versus host disease by cytomegalovirus. J Clin Pathol (1992) 1.25
Genomic sequence and transcriptional profile of the boundary between pericentromeric satellites and genes on human chromosome arm 10q. Hum Mol Genet (2000) 1.25
Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data. Oncogene (2007) 1.24